--- title: GLP-1 Medication Usage and Attitudes Study description: Kantar's GLP-1 injectable medications (Ozempic, Wegovy) usage and attitudes study for weight-loss drugs, healthy eating and lifestyle, shopping pattern. image: https://retailiq.kantar.com/hubfs/1185840420-1.jpg --- [![KANTAR\_Small\_Logo\_White\_RGB](https://retailiq.kantar.com/hubfs/KRiQ%20Atlas%20Integration/KANTAR_Small_Logo_White_RGB.svg "KANTAR_Small_Logo_White_RGB")](https://www.kantar.com/) SHOPPER # GLP-1 & weight loss medications The GLP-1 and injectable medications (such as Ozempic) usage and attitudes syndicated study is for companies seeking a strategic view of the impact of GLP-1 medications. *Now available: Quarterly US study, international markets including Mexico, Brazil, Canada, China, India, Australia, UK, France, Germany, Italy, Spain, as well as Life After GLP-1.* ### To learn more about the study, fill out the form below ## Benefitting from Change: GLP-1 ### Bringing clarity and insight to map the impact of pharma innovation on food, beverage & beyond   ![Picture1-Nov-04-2024-01-44-30-4747-PM](https://retailiq.kantar.com/hs-fs/hubfs/Picture1-Nov-04-2024-01-44-30-4747-PM.jpg?width=389&name=Picture1-Nov-04-2024-01-44-30-4747-PM.jpg "Picture1-Nov-04-2024-01-44-30-4747-PM") ### Understanding GLP-1 users Who, when, and why do they use medications and what is their journey What are users striving for and how are they adopting healthy lifestyles? ![Picture2-4](https://retailiq.kantar.com/hs-fs/hubfs/Picture2-4.jpg?width=389&name=Picture2-4.jpg "Picture2-4") ### Consumption choices What impact GLP-1s have on what they buy, eat and how they are choosing How much do GLP-1s change shopping patterns plus where and what they put in/on their bodies? ![Picture3-3](https://retailiq.kantar.com/hs-fs/hubfs/Picture3-3.jpg?width=391&name=Picture3-3.jpg "Picture3-3") ### Impact beyond food Beyond consumption, what other parts of their lives are being shifted/reinvented From work to fitness to travel, how can we support their renewed approach? ### Kantar's global syndicated GLP-1 studies   ![glp1-2](https://retailiq.kantar.com/hs-fs/hubfs/glp1-2.png?width=1280&height=720&name=glp1-2.png) ### GLP-1 Syndicated Study - International **Now available** - Markets include: US, Mexico, Brazil, Canada, China, India, Australia, UK, France, Germany, Italy, Spain - One-time fielding, you'll get - 50+ pages of reporting - Comparison across US & International - Standalone report for each country purchased - Complete data file ![GLP](https://retailiq.kantar.com/hs-fs/hubfs/GLP.jpg?width=2948&height=1650&name=GLP.jpg) ### GLP-1 Syndicated Study - US Current US GLP-1 users’ attitudes and usage patterns: who are they?  What do they consume?  How do they shop? What is their outlook? What you'll get: - 100+ page report each quarter - Questionnaire and data tables - Quarterly trends and news       # A holistic look into GLP-1 and how shoppers are responding to the latest pharma innovation. Data will be fielded throughout the year with insights available quarterly. | WHAT YOU WILL LEARN | HOW YOU USE IT | THE DETAILS YOU NEED | | --- | --- | --- | | - Who uses GLP-1 medications? How is their lifestyle evolving? - **What is the** **impact on manufacturers and retailers?** - **How much to GLP-1s change shopping patterns as far as where and what they eat?** | - Comprehend this rapidly evolving space by understanding the demographics and attitudes of users - Understand user' needs for products, innovation, and experience at retail - Build strategy for major shifts due to the rapid adoption of this drug | Fully sliceable complete databook for each wave Customize the study to meet your needs: add search analytics, future-planning, and GTM scenarios | ## Become a VIP to adapt the study to fit your business needs With a VIP partnership, you can make sure the study will yield answers to your burning questions about shoppers and how they are reacting to and using GLP-1 medications. Contact us for more information at [KantarShopper@kantar.com](mailto:KantarShopper@kantar.com) --- # [BLOG Tastes they are a-changing: The next phase of GLP-1 innovation  So much of the conversation around GLP-1 medications has focused on what consumers are doing less of: snacking, eating big meals, spending in restaurants. While several of those shifts are real, the latest wave of Kantar’s GLP-1 research suggests that multiple factors beyond “less” are in play. These distinctions signal ongoing innovation opportunities for food manufacturers, retailers, restaurants, and wellness brands. [Read more](https://kriq.kantarretailiq.com/en/p-iq/insights/blogs/tastes-they-are-a-changing-the-next-phase--of-glp-1-innovation)](https://kriq.kantarretailiq.com/en/p-iq/insights/blogs/tastes-they-are-a-changing-the-next-phase--of-glp-1-innovation) ![1160670986 copy](https://retailiq.kantar.com/hubfs/1160670986%20copy.jpeg) ### [BLOG The two Americas of GLP-1 Scroll TikTok long enough and you’ll find two very different GLP-1 stories, often back-to-back. There’s the idea of GLP-1 as self-care, where treating metabolic disease is seen as a positive, liberating experience. Then there’s the “ozempademic” and “SkinnyTok” narrative, where people push back on the use of GLP-1s for aesthetic weight loss. It’s the same molecule and same injection, but with two completely different interpretations. [Read more](https://kriq.kantarretailiq.com/en/p-iq/insights/blogs/the-two-americas-of-glp1)](https://retailiq.kantar.com/health-and-wellness-2023?hsLang=en) ![GettyImages-586076741-600x400-f5be660](https://retailiq.kantar.com/hubfs/GettyImages-586076741-600x400-f5be660.jpeg)   EXPERT SPOTLIGHT ## Kantar's Retail, Sales, and Shopper Experts Answering your most pressing questions related to shopper commerce. ![Leigh\_20](https://retailiq.kantar.com/hubfs/Leigh_20.jpg) Leigh O'Donnell Head of Shopper and Category Insights & Solutions ![brettwhitfield.m\_KANTAR\_039](https://retailiq.kantar.com/hubfs/KRiQ%20Atlas%20Integration/Headshot%20Crop/brettwhitfield.m_KANTAR_039.jpg) Mary Brett Whitfield Senior Vice President Shopper Insights ![Craig\_Julie\_Kantar-1](https://retailiq.kantar.com/hubfs/Craig_Julie_Kantar-1.jpg) Julie Craig Vice President Shopper Insights Looking for insights? #### Take a look at content catered to you. ### Retail Sound Bites The Kantar Sound Bites podcast provides a provocative view of global retail trends, category leadership, business issues, and other shopper and retail related news.  [Subscribe to the Podcast](https://retailiq.kantar.com/retail-sound-bites?hsLang=en) ![podcast equipment microphone](https://retailiq.kantar.com/hubfs/podcast%20equipment%20microphone.jpeg) ### Retail Media Networks B2B Benchmarking Study Closing the trust gap between brands and retailers [Learn more](https://retailiq.kantar.com/retail-media-networks?hsLang=en) ![2-2](https://retailiq.kantar.com/hubfs/2-2.png) ### Commerce rewired: Kantar's 2026 POV In 2026, resilience, relevance, and relationships are no longer optional. They are competitive requirements. Retailers and suppliers face rising costs, fractured partnerships, private label pressure, and increasingly nonlinear shopper journeys. [Download the Report](https://retailiq.kantar.com/commerce-rewired-2026-retail-themes?hsLang=en) ![Commerce Rewired](https://retailiq.kantar.com/hubfs/photoshop%20theme%20cover%20with%20K.png) ![KANTAR\_Small\_Logo\_White\_RGB](https://retailiq.kantar.com/hubfs/KRiQ%20Atlas%20Integration/KANTAR_Small_Logo_White_RGB.svg "KANTAR_Small_Logo_White_RGB") Copyright © 2026 Kantar #### Company - [Terms of use](https://www.kantar.com/Terms-and-Conditions) - [Kantar Retail IQ Privacy Policy](https://retailiq.kantar.com/privacy-policy) - [About Kantar](https://www.kantar.com/About) - [Privacy](https://www.kantar.com/Cookies-Policies)